Aragen, a Contract Research Development and Manufacturing Organization (CRDMO) for small molecules and biologics, has operationalized the first phase of its biologics manufacturing facility in Bangalore, India through its subsidiary, Aragen Biologics Pvt Ltd. The facility is being set up with an investment of $30 million and has executed its first small-scale manufacturing project for a U.S.-based organization for an anticancer monoclonal antibody (mAb). The non-GMP facility can undertake batch ...